Vasopharm is a company which specializes in researching and developing novel therapeutics and the treatment of cerebro- and cardiovascular diseases and their consequences. It is focused on small molecule therapeutics for treatment of Traumatic Brain Injury (TBI) and aims to avoid side effects and increase clinical efficiency in treatment.
|Employees (est.) (Sept 2020)||11|
Vasopharm total Funding
Vasopharm latest funding size
Time since last funding
|a year ago|
|Entrepreneurs Fund, 3i Group, EMBL Ventures, Bayern Kapital, Heidelberg Innovation, Fort Rock Capital, Hanseatic Asset Management, Heidelberg Capital Private Equity, Bayern Kapital GmbH, EF Investments, Future Capital Development Fund, Rington Holdings|
When was Vasopharm founded?
Vasopharm was founded in 1998.
Who are Vasopharm key executives?
Vasopharm's key executives are Christian Wandersee, Andrew Clark and Frank Tegtmeier.
How many employees does Vasopharm have?
Vasopharm has 11 employees.
Who are Vasopharm competitors?
Competitors of Vasopharm include Forever Labs, Linical and NorInvent.
Where is Vasopharm headquarters?
Vasopharm headquarters is located at Friedrich-Bergius-Ring 15, Würzburg.
Where are Vasopharm offices?
Vasopharm has an office in Würzburg.
How many offices does Vasopharm have?
Vasopharm has 1 office.
Receive alerts for 300+ data fields across thousands of companies